New smart system aims to catch dangerous blood pressure drops earlier

NCT ID NCT07309666

Not yet recruiting Diagnosis Sponsor: Xuanwu Hospital, Beijing Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test a new intelligent diagnostic system for orthostatic hypotension (a sudden drop in blood pressure when standing up). The system continuously monitors blood pressure, brain blood flow, and heart signals to classify the condition more precisely. Researchers plan to enroll 2000 adults with Parkinson's disease, multiple system atrophy, or diabetes who may have orthostatic hypotension. The goal is to create a risk-stratification model that could improve early detection and management.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Intelligent diagnostic system (non-invasive monitoring of blood pressure, brain blood flow, and heart signals)
What this could lead to: If successful, this could lead to a more accurate and automated way to diagnose and classify orthostatic hypotension, potentially reducing falls and disability in elderly and at-risk patients.
What could go wrong: This is an early-stage diagnostic study, not a treatment trial. The system may not prove accurate enough for widespread use, and results may not apply to all patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus Hypotension, Orthostatic multiple system atrophy orthostatic hypotension Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ORTHOSTATIC HYPOTENSION

Contacts and locations

Locations

Xuanwu Hospital, Capital Medical University

Beijing, Beijing Municipality, 100053, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.